2,364
Views
25
CrossRef citations to date
0
Altmetric
Article

Synthesis, characterization, biocompatibility of hydroxyapatite–natural polymers nanocomposites for dentistry applications

, , , , , , , , , & show all
Pages 277-284 | Received 12 Jun 2014, Accepted 10 Jul 2014, Published online: 11 Aug 2014

References

  • Abbasi E, Akbarzadeh A, Kouhi M, Milani M. 2014a. Graphene: synthesis, bio-applications, and properties. Artif Cells Nanomed Biotechnol 43:1–7.
  • Abbasi E, Fekri Aval S, Akbarzadeh A, Milani M, Tayefi Nasrabadi H, Joo SW, et al. 2014b. Dendrimers: synthesis, applications and properties. Nanoscale Res Lett. 9:247
  • Abbasi E, Milani M, Fekri Aval S, Kouhi M, Akbarzadeh A, Tayefi Nasrabadi H, et al. 2014c. Silver nanoparticles: synthesis, properties, bio-applications and limitations. Crit Rev Microbiol. 1–8.
  • Adlar G, Ballamtin D, Baysal B. 1960The mechanism of free radical polymerization in the solid state. J Polym Sci. 48:195–206.
  • Ahmadi A, Shirazi H, Pourbagher N, Akbarzadeh A, Omidfar K 2014. An electrochemical immunosensor for digoxin using core-shell gold coated magnetic nanoparticles as labels. Mol Biol Rep. 41:1659–1668.
  • Akbarzadeh A, Mikaeili H, Asgari D, Zarghami N, Mohammad R, Davaran S. 2012a. Preparation and in-vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 7:511–526.
  • Akbarzadeh A, Mohamad S, Davaran S. 2012b. Magnetic nanoparticles: preparation, physical properties and applications in biomedicine Nanoscale Res Lett.7:144–157.
  • Akbarzadeh A, Nejati-Koshki K, Soghrati MM, Alimohammadi S, Ghamari MF, Davaran S. 2013a. In vitro studies of NIPAAM-MAA-VP copolymer-coated magnetic nanoparticles for controlled anticancer drug release J Encapsulation Adsorpt Sci.3:108–115.
  • Akbarzadeh A, Rezaei A, Nejati-Koshki K, Alimohammadi S, Davaran S. 2014. Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide– β-cyclodextrin copolymer nanoparticles containing albumin Adv Nanoparticles3:14–22.
  • Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013b. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8:102.
  • Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S. 2012c. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line J Nanobiotechnol. 10:46.
  • Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Davaran S. 2012d. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Int J Nanotechnol Sci Environ. 5:13–25
  • Alimirzalu S, Akbarzadeh A, Abbasian M, Alimohammadi S, Davaran S, Hanifehpour Y, et al. 2014. Synthesis and study of physicochemical characteristics of Fe3O4 magnetic nanocomposites based on poly(Nisopropylacrylamide)for anti-cancer drugs delivery. Asian Pac J Cancer Prev. 15:49–54.
  • Alizadeh E, Akbarzadeh A, Zarghami N, Eslaminejad MB, Hashemzadeh S, Nejati-Koshki K. 2014a. Up-regulation of liver enriched transcription factors (HNF4a and HNF6) and liver specific microRNA (miR-122) by inhibition of Let-7b in mesenchymal stem cells. Chem Biol Drug Design(in press)
  • Alizadeh E, Zarghami N, Eslaminejad MB, Akbarzadeh A, Barzegar A, Mohammadi SA. 2014b. The effect of dimethyl sulfoxide (DMSO) on hepatic differentiation of mesenchymal stem cells. Artif Cells Nanomed Biotechnol 43:1–8.
  • Alizadeh E, Zarghami N, Eslaminejad MB, Akbarzadeh A, Jahangir S, Barzegar A, et al. 2014c. The effect of dimethyl sulfoxide on hepatogenic differentiation of mesenchymal stem cells. Int J Pediatrics (2):57–58.
  • Anganeh MT, Sadat Tabatabaei Mirakabad F, Izadi M, Zeighamian V, Badrzadeh F, Salehi R, et al. 2014. The comparison between effects of free curcumin and curcumin loaded PLGA-PEG on telomerase and TRF1 expressions in calu-6 lung cancer cell line. Int J Biosci. 4:134–145.
  • Apicella A, Hopfenberg HB. 1978. The effects of thermal treatment, residual solvent, and preswelling on the thermal properties and sorption behavior of poly(2,6-dimethyl, 1,4-phenylene oxide)- polystyrene blends. P olym Eng Sci. 18:1006–1011.
  • Athanasiou KA, Zhu CF, Lanctot DR, Agrawal CM, Wang X. 2000. Fundamentals of biomechanics in tissue engineering of bone. Tissue Eng. 6:361–381.
  • Balamurugan A, Michel J, Faure J, Benhayoune H, Wortham L, Sockalingum G, et al. 2006. Synthesis and structural analysis of sol gel derived stoicheometric monophasic hydroxyapatite. Ceramics-Silikaty. 50:27–31.
  • Banker GS. 1984. Medical Application of Controlled Release. Boca Raton, FL: CRC Press Inc.
  • Barinov SM, Komlev VS, Smirnov VV, Fadeeva IV, Fomin AS. 2008. Advanced nanoceramics for bone tissue engineering powder. Metall Prog. 8:331–335.
  • Benedtti LM, Toppa EM, Stella VJ. 1990. Microspheres of hyaluronic acid esters—Fabrication methods and in vitro hydrocortisone release. J Control Release. 13:33.
  • Bouwstra JA, Jungiger HE. 1993. Encyclopedia of Pharmaceutical Thecnology. New York: Marcel Dekker, 7:441.
  • Bouyer E, Gitzhofer F, Boulos MI. 2000. Morphological study of hydroxyapatite nanocrystal suspension. J Mater Sci Mater Med. 11:523–531.
  • Brendel T, Engel A, Russel C. 1992. Hydroxyapatite coating by polymeric route J Mater Sci Mater Med. 3:175–179.
  • Dash AK, Cudworth GC. 1998. Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods. 40:1–12.
  • Davoudi Z, Akbarzadeh A, Rahmatiyamchi M, Movassaghpour AA, Alipour M, Nejati-Koshki K, et al. 2014. Molecular target therapy of Akt and NF-kB signaling pathways and multidrug resistanceby specific cell penetrating inhibitor peptides in HL-60 cell line. APJCP. 9:4353–4358.
  • Deer WA, Howie RA 1985. An Introduction to the Rock Forming Minerals. Longman: Harlow, 504–509.
  • Drotleff S, Lungwitz U, Breunig M, Dennis A, Blunk T, Tessmar J, Gopferich A. 2004. Biomimetic polymers in pharmaceutical and biomedical sciences. Eur J Pharm Biopharm. 58:385–407.
  • Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N, Akbarzadeh A, et al. 2014a. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett. (in press)
  • Eatemadi A, Daraee H, Zarghami N, Melat Yar H, Akbarzadeh A, Hanifehpour Y. 2014b. Nanofiber: synthesis and biomedical applications. Artif Cells Nanomed Biotechnol. 1:1–11
  • Ebrahimi E, Abbasi E, Akbarzadeh A, Khandaghi AA, Davaran S. 2014. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer. Artif Cells Nanomed Biotechnol(in press)
  • Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh A, Rahmati M, et al. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. Bioimpacts. 3:67–74.
  • Fekri Aval S, Akbarzadeh A, Yamchi MR, Barkhordari A, Mohamadzadeh N, Nejati-Koshki K, et al. 2014. Gene silencing effect of SiRNA-magnetic copolymers on hTERT gene expression in lung cancer cell line Artif Cells Nanomed Biotechnol(in press)
  • Ferraz MP, Monteri FJ, Manuel CM. 2004. Hydroxyapatite nanoparticles: a review of preparation methodologies. J Appl Biomater Biomech. 2:74–80.
  • Flooladi M. 1978. Synthesis and Charactrization and Release Study of the Polymer with Pendent Pesticide. Ph.D. Thesis.
  • Fuge KF, Saltzman WM. 1997. Polymeric implants for cancer chemotherapy. Adv Drug Deliv Rev. 26:209–230.
  • Ghalhar MG, Akbarzadeh A, Rahmati M, Mellatyar H, Dariushnejad H, Zarghami N. 2014. Comparison of inhibitory effect of 17-AAG nanoparticles and free 17-AAG in HSP90 gene expression in breast cancer. APJCP. (in press)
  • Ghasemali S, Akbarzadeh A, Alimirzalu S, Rahmati Yamchi M, Barkhordari A, Tozihi M, Kordi SH, et al. 2013. Study of inhibitory effect of β-cyclodextrin-helenalincomplex on HTERT gene expression in T47D breast cancer cell line by real time quantitative PCR (q-PCR) APJCP. 14:6949–6953.
  • Granja PL, Silva AIN, Borges JP, Barrias CC, Amaral IF. 2004. Preparation and Characterization of Injectable Chitosan-Hydroxyapatite Microspheres. Key Eng Mat. 254–256:573–576.
  • Harris FW. 1984. Medical Application of Controlled Release. Boca Raton, Florida: CRC Press Inc.
  • Hosseininasab S, Pashaei‐Asl R, Khandaghi AA, Nasrabadi HT, Nejati‐Koshki K, Akbarzadeh A, et al. 2014. Synthesis, characterization, and in vitro studies of PLGA‐PEG nanoparticles for oral insulin delivery. Chem Biol Drug Desi. 84:349–357.
  • Janackovic D, Petrovic-Prelevic I, Kostic-Gvozdenovic L, Petrovic R, Jokanovic V, Uskokovic D. 2001. Influence of synthesis parameters on the particle sizes of nanostructured calciumhydroxyapatite. Key Eng Mater. 192–195:203–206.
  • Jarcho M, Kay JF, Gumar KI, Doremus RH, Drobeck HP. 1977. Tissue, cellular and subcellular events at a bone ceramic hydroxyapatite interface. J Biosci Bioeng. 1:79–92.
  • Kaetsu I, Uchida K, Sutani K, Tankaa S, Okada K. 1993. Controlled Realease Society,Lincolnshire, IL. p 352.
  • Karnoosh-Yamchi J, Mobasseri M, Akbarzadeh A, Davaran S, Ostad-Rahimi AR, Hamishehkar H, et al. 2014. Preparation of pH sensitive insulin-loaded Nano hydrogels and evaluation of insulin releasing in different pH conditions. Mol Biol Rep. (in press)
  • Kaye TM. 1989. Sales From Focus Polymers, High Performance Fibers From Focus Polymer.9:5–6.
  • Kimura I. 2007. Synthesis of hydroxyapatite by interfacial reaction in a multiple emulsion. Res Lett Mater Sci. Article ID 71284, 1–4.
  • Kost J, Langer R. 1984. Controlled release of bioactive agents. Trends Biotechnol. 2:47.
  • Kouhi M, Vahedi A, Akbarzadeh A, Hanifehpour Y, Joo SW. 2014. Investigation of quadratic electro-optic effects and electro absorption process in GaN/AlGaN spherical quantum dot. Nanoscale Res Lett. 9:1–6.
  • Kumar CSSR. 2006. Biological and Pharmaceutical Nanomaterials. Wiley: Hoboken.
  • Kuzuya M, Kondo S. 1991The Nature of Hydrolysis of Novel Methacryloyl Polymeric Prodrugs Prepared by Mechanochemical Solid State Polymerization. Chem Pharm Bull. 39:3018–3022.
  • Lando JB, Morawezt HJ. 1963. Polymerization in the crystalline state. IV. Calcium acrylate and barium methacrylate. Polym Sci Polym Chem Ed. 19:789.
  • Langer R. 1990. New methods of drug delivery. Science. 249:1527–33.
  • Lee KL. 2005. Design parameters of polymers for tissue engineering applications. MacromolRes. 13:277–284.
  • Lim YB. 1999. A self destroying polycationic polymer: biodegrable polyester, poly (4-hydroxyl-L-proline ester). J Am Chem Soc. 121:5633.
  • Manafi SA, Joughehdoust S. 2009. Synthesis of hydroxyapatite nanostructure by hydrothermal condition for biomedical application. Iranian J Pharm Sci.5:89–94.
  • Manso M, Jimenez C, Morant C, Herrero P. 2000. Electrodeposition of hydroxyapatite coatings in basic conditions. Biomaterials. 21:1755–1761.
  • Manuel CM, Ferraz MP, Monteiro FJ. 2003. Synthesis of hydroxyapatite and tri calcium phosphate nanoparticles. Preliminary Studies Key Eng Mater. 240–242:555–558.
  • Mirth DB. 1980. The use of controlled and sustained release agents in dentistry: a review of applications for the control of dental caries. Pharmacol Ther Dent. 5:59.
  • Mollazade M, Nejati-Koshki K, Akbarzadeh A, Hanifehpour Y, Zarghami N, Joo SW. 2013. PAMAM dendrimers arugment inhibitory effect of curcumin on cancer cell proliferation: possible inhibition of telomerase. APJCP. 14:6925–6928.
  • Montazeri N, Jahandideh R, Biazar E. 2011. Synthesis of fluorapatite– hydroxyapatite nanoparticles and toxicity investigations. Int J Nanomedicine. 6:197–201.
  • Myer K. 2003. Standard Handbook of Biomedical Engineering and Design. McGRAW-HILL: New York.
  • Nair LS, Laurencin GT. 2006. Polymers as biomaterials for tissue engineering and controlled drug delivery. Adv Biochem Eng B iotechnol. Adv biochem Eng Biotechnol. 102:47–90.
  • Nayak AK. 2010. Hydroxyapatite synthesis methodologies: an overview. Int J ChemTech Res. 2:903–907. ISSN: 0974-4290.
  • Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghadam M, Joo SW. 2013. Inhibition of leptin and leptin receptor gene expression by silibinin- curcumin combination. APJCP. 14:6595–9.
  • Nejati-Koshki K, Akbarzadeh A, Pourhassan-Moghaddam M, Joo SW, Hanifepour Y. 2014a. Curcumin inhibit leptin gene expression and secretion in breast cancer cells by estrogen receptors. Cancer Cell Int(in press).
  • Nejati-Koshki K, Mesgari M, Ebrahimi E, Abhari A, Fekri Aval S, Khandaghi AA, Akbarzadeh A. 2014b. Synthesis and in-vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer. J Microencapsul. (in press).
  • Oh S, Oh N, Appelford M, Ong JL. 2006. Bioceramics for tissue engineering applications-a review. Am J Biochem Biotechnol. 2:49–56.
  • Oliveiraa JM, Rodrigues MT,Silva SS, Malafaya PB, Gomes ME, Viegas CA, et al. 2006. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells. Biomaterials. 27:6123–6137.
  • Peppas NA, Khare AR. 1993. Preparation, Structure and Diffusional Behavior of Hydrogels in Controlled Release. Adv Drug Del Rev. 11:1.
  • Peppas NA, Mikos AG. 1986. Hydrogels in Medicine and Pharmacy. Boca Raton, FL: CRC Press. 1:1–27.
  • Pourhassan-Moghaddam M, Rahmati-Yamchi M, Akbarzadeh A, Daraee H, Nejati-Koshki K, Hanifehpour Y, Joo SW. 2013. Protein detection through different platforms of immuno-loop-mediated isothermal amplification. Nanoscale Res Lett. 8:485.
  • Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, Rahmati-Yamchi M, Gholizadeh D, Akbarzadeh A, et al. 2014. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. Micro Nano Lett 9:345–350.
  • Ratner BD, Hoffman AS, Schoen FJ, Lemons JE. 2004. Biomaterials Science, An Introduction to Materials in Medicine. 2nd ed. London: Academic Press, pp. 162.
  • Rezaei-Sadabady R, Zarghami N, Barzegar A, Eidi A, Akbarzadeh A, Rezaei-Tavirani M. 2013. Studies of the relationship between structure and antioxidant activity in interesting systems, including tyrosol, hydroxytyrosol derivatives indicated by quantum chemical calculations. Soft. 2:13–18.
  • Sadat Tabatabaei Mirakabad F, Akbarzadeh A, Zarghami N, Zeighamian V, Rahimzadeh A, Alimohammadi S. 2014. PLGA-based nanoparticles as cancer drug delivery systems Asian Pac J Cancer Prev. 15:517–535.
  • Santos C, Luklinska ZB. 2001. Hydroxyapatite as a filler for dental composite materials: mechanical properties and in vitro bioactivity of composites. J Mater Sci. 12:565–573.
  • Santos MH, Oliveira M, Freitas Souza P, Mansur HS, Vasconcelos WL. 2004. Synthesis control and characterization of hydroxyapatite prepared by wet precipitation process. Mater Res. 7:625–630.
  • Sopyan I, Mel M, Ramesh S, Khalid KA. 2007. Porous hydroxyapatite for artificial bone applications. Sci Technol Adv Mat. 8:116–123.
  • Stamatialis DF, Papenburg BJ, Girones M, Saiful S, Bettahalli SNM. 2008. Medical applications of membranes: drug delivery, artificial organs and tissue engineering. J Memb Sci. 309:1–34.
  • Stauffer SR, Peppas NA. 1992Poly(vinyl alcohol) hydrogels prepared by freezing-thawing cyclic processing. Polymer 33:3932–3936.
  • Takahashi H, Yashima M, Kakihana M, Yoshimura M. 1995. Synthesis of stoichiometric hydroxyapatite by a gel route from the aqueous solution of citric and phosphoneacetic acids. Eur J Solid State Inorg Chem. 32:829–835.
  • Tathe A, Ghodke M, Nikalje AP. 2010. A brief review: biomaterials and their application. Int J Pharm Pharmaceutical Sciences. 2:19–23. ISSN- 0975-1491.
  • Teoh SH. 2004. Engineering Materials for Biomedical Applications. Hackensack, NJ: World Scientific Pub.
  • Thamaraiselive TV, Rajeswari S. 2004. Biological evaluation of bioceramic materials: a review. Trends Biomater Artif Organs. 18:9–17.
  • Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M, et al. 2012. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett. 7:276.
  • Vert M, Li S, Garreau H. 1991. More about the degradation of LA/GA-derived matrices in aqueous media. J Control Release. 16:15–26.
  • Vijayalakshmi U, Rajeswari S. 2006. Preparation and characterization of microcrystalline hydroxyapatite using sol gel method. Trends Mater Artif Org. 19:57–62.
  • Wang L, Li CZ. 2007. Preparation and physicochemical Properties of a novel hydroxyapatite/chitosan-silk fibroin composite. Carbohydr Polym. 68:740–745.
  • Wang M. 2003. Developing bioactive composite materials for tissue replacement. Biomaterials. 24:2133–2151.
  • Weiner S, Wolfie T, Wagner HD. 1999. Lamellar bone: structure- function relations. J Struct Biol. 126:241–255.
  • Xuan C, Hua T, Xinyu S. 2009. Preparation and characterization of homogeneous chito-san–polylactic acid/hydroxyapatite nanocomposite for bone tissue engineering and evaluation of its mechanical properties. Acta Biomater. 7:2693–2703.
  • Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG. 1996. Evolution of bone transplantation: Molecular, cellular and tissue strategies to engineer human bone. Biomaterials. 17: 175–185.
  • Zohre S, Akbarzadeh A, Kazem NJ, Nosratollah Z, Mohammad R, Aliakbar M, et al. 2014. Enhanced expression of klf4 and apoptosis in ovarian and lung cancer by histone deacetylase inhibitor: Trichostatin A. APJCP. 2014:9.p.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.